Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.
1:23-cv-01264
Overview
Parties
Defendant
Scilex Holding Company NPE (Individual / Inventor)
Represented By
5 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., DE
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Scilex Pharmaceuticals Inc. Operating Company
Represented By
5 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., DE
Phillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Plaintiff
Takeda Pharmaceuticals U.S.A., Inc. Operating Company
Represented By
4 Attorneys ListedFaegre Drinker Biddle & Reath LLP
222 Delaware Avenue, Suite 1410
Faegre Drinker Biddle & Reath LLP
222 Delaware Avenue, Suite 1410
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 8 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US7619004
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2008-12-03
Issued: 2009-11-17
|
Active (2.0 yrs remaining)
Expires: 2028-12-03
|
|
|
US7820681
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2009-02-17
Issued: 2010-10-26
|
Active (2.2 yrs remaining)
Expires: 2029-02-17
|
|
|
US7964648
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2010-01-15
Issued: 2011-06-21
|
Active (3.2 yrs remaining)
Expires: 2030-01-15
|
|
|
US8093297
Methods for concomitant administration of colchicine and a second active agent
|
Filed: 2011-04-22
Issued: 2012-01-10
|
Active (4.4 yrs remaining)
Expires: 2031-04-22
|
|
|
US8097655
Methods for concomitant administration of colchicine and macrolide antibiotics
|
Filed: 2011-05-17
Issued: 2012-01-17
|
Active (4.5 yrs remaining)
Expires: 2031-05-17
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).